Delivery Order SPE2DB22D3010-SPE2DB25FP1HD

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,129.68 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of May 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,053.73 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a period of performance through December 9, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,597.34 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The contract has an ultimate completion date of October 28, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,901.70, is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,605.50 firm fixed-price delivery order contract is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The contract has an ultimate completion date of November 1, 2024 and is not designated with a set-aside requirement, indicating open competition. This award is associated with a larger...
This federal contract award, valued at $51,779.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,368.76 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,355.70 delivery order contract is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 21, 2024. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $3,131.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,111.66 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a performance period through December 23, 2024. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB25FP1HD
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,480.98 Firm Fixed Price Delivery Order contract has an ultimate completion date of January 6, 2025 and covers the procurement of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as a primary contract vehicle for the company to deliver essential medical commodities, including specialty medications, generic and brand-name drugs, vaccines, syringes, and other critical medical items across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition.

Generated 4/4/25, 9:55 AM